Guanfacine Impurity 13 | CAS 130974-86-6 - Request Quote
Guanfacine Impurity 13
| SZ CAT No: | SZ-G033023 |
| CAS No | 130974-86-6 |
| Mol.F. | C7H8ClN3O |
| Mol.Wt. | 185.6 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 497874-91-6 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Guanfacine Impurity 13 is chemically 1-(4-Chlorophenyl)-3-hydroxyguanidine. Guanfacine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Guanfacine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Guanfacine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 130974-86-6
Purchase 130974-86-6
Order 130974-86-6
Enquire 130974-86-6
price of 130974-86-6
130974-86-6 Supplier
130974-86-6 Manufacturer
130974-86-6 Exporter
buy high quality Guanfacine Impurity 13
Purchase Guanfacine Impurity 13
Guanfacine Impurity 13 suppliers
Guanfacine Impurity 13 manufacturers
Guanfacine Impurity 13 price
Order Guanfacine Impurity 13
Enquire Guanfacine Impurity 13
Guanfacine Impurity 13 cost
Guanfacine Impurity 13 Supplier
Guanfacine Impurity 13 Distributor
Guanfacine Impurity 13 for Method Validation
Guanfacine Reference Standard
Guanfacine Impurity 13 for ANDA Filing
Guanfacine Impurity 13 for Forced Degradation Studies
Guanfacine Impurity 13 Identification Standards
Guanfacine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


